Circio Holding ASA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Circio Holding ASA
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.
/ 
Frequently asked questions
To buy Circio Holding ASA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Circio Holding ASA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Circio Holding ASA is CRNA:xosl. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Circio Holding ASA has its primary listing on Oslo Børs/Oslo Stock Exchange. You can trade Circio Holding ASA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Circio Holding ASA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Circio Holding ASA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Circio Holding ASA.